| Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. | |
| | |
MedLine Citation:
|
PMID: 16294266 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A murine segmental femoral bone graft model was used to show the essential role of donor periosteal progenitor cells in bone graft healing. Transplantation of live bone graft harvested from Rosa 26A mice showed that approximately 70% of osteogenesis on the graft was attributed to the expansion and differentiation of donor periosteal progenitor cells. Furthermore, engraftment of BMP-2-producing bone marrow stromal cells on nonvital allografts showed marked increases in cortical graft incorporation and neovascularization, suggesting that gene-enhanced, tissue engineered functional periosteum may improve allograft incorporation and repair. INTRODUCTION: The loss of cellular activity in a structural bone allograft markedly reduces its healing potential compared with a live autograft. To further understand the cellular mechanisms for structural bone graft healing and repair and to devise a therapeutic strategy aimed at enhancing the performance of allograft, we established a segmental femoral structural bone graft model in mice that permits qualitative and quantitative analyses of graft healing and neovascularization. MATERIALS AND METHODS: Using this segmental femoral bone graft model, we transplanted live isografts harvested from Rosa 26A mice that constitutively express beta-galactosidase into their wildtype control mice. In an attempt to emulate the osteogenic and angiogenic properties of periosteum, we applied a cell-based, adenovirus-mediated gene therapy approach to engraft BMP-2-producing bone marrow stromal cells onto devitalized allografts. RESULTS: X-gal staining for donor cells allowed monitoring the progression of periosteal progenitor cell fate and showed that 70% of osteogenesis was attributed to cellular proliferation and differentiation of donor progenitor cells on the surface of the live bone graft. Quantitative muCT analyses showed a 3-fold increase in new bone callus formation and a 6.8-fold increase in neovascularization for BMP-2/stromal cell-treated allograft compared with control acellular allografts. Histologic analyses showed the key features of autograft healing in the BMP-2/stromal cell-treated allografts, including the formation of a mineralized bone callus completely bridging the segmental defects, abundant neovascularization, and extensive resorption of bone graft. CONCLUSIONS: The marked improvement of healing in these cellularized allografts suggests a clinical strategy for engineering a functional periosteum to improve the osteogenic and angiogenic properties of processed allografts. |
| | |
Authors:
|
Xinping Zhang; Chao Xie; Angela S P Lin; Hiromu Ito; Hani Awad; Jay R Lieberman; Paul T Rubery; Edward M Schwarz; Regis J O'Keefe; Robert E Guldberg |
Related Documents
:
|
15785286 - Bone flap prefabrication: an experimental study in rabbits. 11928906 - Bone allografts pretreated with a bisphosphonate are not resorbed. 320296 - Bone grafts with surface decalcified allogeneic and particulate autologous bone: report... 12435946 - Heterotopic neo-osteogenesis from vascularized periosteum and bone grafts. 3522686 - International dermatosurgery: use of medial plantar based skin flaps for correction of ... 21904256 - Surgical versus non-operative treatment of hadley type iia odontoid fractures. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. Date: 2005-08-08 |
Journal Detail:
|
Title: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Volume: 20 ISSN: 0884-0431 ISO Abbreviation: J. Bone Miner. Res. Publication Date: 2005 Dec |
Date Detail:
|
Created Date: 2005-11-18 Completed Date: 2006-02-27 Revised Date: 2009-04-28 |
Medline Journal Info:
|
Nlm Unique ID: 8610640 Medline TA: J Bone Miner Res Country: United States |
Other Details:
|
Languages: eng Pagination: 2124-37 Citation Subset: IM |
Affiliation:
|
Department of Orthopaedics, University of Rochester Medical Center, New York, USA. Xinping_Zhang@URMC.rochester.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acid Phosphatase
/
metabolism Alkaline Phosphatase / metabolism Animals Bone Marrow Transplantation Bone Morphogenetic Protein 2 Bone Morphogenetic Proteins / genetics, metabolism Bone Regeneration / physiology* Bone Remodeling / physiology Bone Transplantation* Bone and Bones / blood supply, cytology, metabolism Cartilage / cytology, growth & development Cell Differentiation / physiology Cell Proliferation Gene Therapy / methods Humans Isoenzymes / metabolism Mesenchymal Stem Cells / cytology*, metabolism Mice Mice, Inbred C57BL Mice, Transgenic Neovascularization, Physiologic / physiology Osteogenesis / physiology Periosteum / blood supply, cytology*, surgery Stromal Cells / metabolism, transplantation Tissue Engineering / methods* Transfection Transforming Growth Factor beta / genetics, metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
AR051336/AR/NIAMS NIH HHS; AR051469/AR/NIAMS NIH HHS; AR45971/AR/NIAMS NIH HHS; AR46545/AR/NIAMS NIH HHS; R01 AR051469-02/AR/NIAMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/BMP2 protein, human; 0/Bmp2 protein, mouse; 0/Bone Morphogenetic Protein 2; 0/Bone Morphogenetic Proteins; 0/Isoenzymes; 0/Transforming Growth Factor beta; EC 3.1.3.-/tartrate-resistant acid phosphatase; EC 3.1.3.1/Alkaline Phosphatase; EC 3.1.3.2/Acid Phosphatase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Next Document: Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of...